HPV infection incidence and genotype distribution among male patients visiting outpatient departments in Huizhou from 2014 to 2023

Table 1 Characteristics of HPV infection by age group and diagnosis [n(%)]

Age Group	Total	Positive	Prevalence	95% CI	Genotype Ranking	Low-Risk Types	High-Risk Types	Mixed Infection
≤ 30	433	127(41.23^c)	29.33	25.00-33.60	HPV6, HPV11	53^a (41.73)	42^a(33.07)	32^a(25.20)
31–40	409	121 (39.29^c)	29.58	25.10–34.00	HPV6, HPV52	37^a (30.58)	63^b(52.07)	21^a(17.36)
41–50	110	41 (13.31^c)	37.27	28.10–46.50	HPV6, HPV52	14^a (34.15)	20^a,b(48.78)	7^a(17.07)
≥ 51	57	19 (6.17^c)	33.33	20.70–46.00	HPV52, HPV6	4^a (21.05)	8^a,b(42.11)	7^a(36.84)
Diagnosis
Viral Warts	81	64 (25.60c)	79.01	70.00-88.10	HPV6, HPV11	40^a(62.50)	11^a(17.19)	13^a(20.31)
Genital papules / Genitourinary inflammation	72	14 (5.60^c)	19.44	10.10–28.80	HPV16, HPV51	3^b(21.43)	6^a,b(42.86)	5^a(35.71)
Fertility Maternity Related	186	46 (18.40^c)	24.73	18.50–31.00	HPV52, HPV51	5^b(10.87)	31^b(67.39)	10^a(21.74)
Check-ups/Other	527	126 (50.40^c)	23.91	20.30–27.60	HPV52, HPV6	32^b(25.40)	72^b(57.14)	22^a(17.46)

Notes:
• The data analysis in this study covers diagnostic data from 2020 to 2023 only, due to unavailability of data from 2014 to 2019
• In this table, “c” represents the proportion of positive samples within each category relative to the total number of positive samples
• Letters “a” and “b” denote different “Age Group” and “Diagnosis” categories, respectively. Comparisons of row proportions between these categories at the 0.05 significance level showed no statistically significant differences

ISSN: 1743-422X